SCHEMBL7011024

SCHEMBL7011024

C=Cc1ccc(S(=O)(=O)CCCC(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 4/20 0.43
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 3/20 0.41
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC11 Q96DB2 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC9 Q9UKV0 2/20 0.41
HDAC5 Q9UQL6 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA2 P00918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11050771 0.90 HTT (0.57) TDP1HTTNPSR1KDM4EALDH1A1
SCHEMBL7869979 0.89 HTT (0.55) TDP1HTTNPSR1KDM4EALDH1A1
SCHEMBL7014407 0.81 KMT2A (0.48) TDP1NPSR1ALDH1A1CYP3A4CYP2C9
SCHEMBL1628717 0.80 MMP2 (0.58) TDP1MMP2MMP7MMP14
SCHEMBL5128861 0.79 HDAC1 (0.60) HTTNPSR1KDM4EALDH1A1HDAC1
SCHEMBL7869982 0.79 TDP1 (0.50) TDP1HTTNPSR1KDM4EALDH1A1
SCHEMBL19066564 0.78 ALDH1A1 (0.69) HTTNPSR1KDM4EALDH1A1CYP3A4
SCHEMBL3107979 0.78 CA2 (0.58) TDP1HTTNPSR1ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL5120938 0.78 HDAC1 (0.58) HTTNPSR1KDM4EALDH1A1HDAC1
SCHEMBL3618282 0.76 SMN1; SMN2 (0.60) ALDH1A1HDAC1HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH TDP1 4829/4885HTT 864/4885NPSR1 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.